Chiesi, the international research-focused biopharmaceutical and healthcare group, has announced that its phase III clinical safety trial for the development of an innovative carbon minimal inhaler platform is underway.1 The carbon minimal inhaler will replace the current hydrofluorocarbon propellant (HFC 134a) .
As part of our Mission Possible campaign, edie delivers this member-exclusive weekly round-up of five of the best sustainable business success stories of the week. In this week's edition, a boost for off-road electric trucks in Africa, and much more.
Ralph Blom - PharmaTimes pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.
Trainersduo Arjan de Zeeuw en Pim Touber langer bij Vitesse'... noordhollandsdagblad.nl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from noordhollandsdagblad.nl Daily Mail and Mail on Sunday newspapers.